Deep Dive Batch 2 — International Names
Second batch: European, Asian, and special-theme holdings
Coverage
European banks, Asian consumer, energy/metals, and other special themes.
Key Holdings
| Ticker | Company | Price | Fwd PE | PB | Div Yield | ROE | Assessment |
|---|---|---|---|---|---|---|---|
| ACN | Accenture | $179 | 12.0x | 4.8 | 1.50% | 29% | Undervalued |
| CB | Chubb | $328 | 11.2x | 1.3 | — | 15% | Undervalued |
| GSK | GSK plc | $51 | 9.8x | 4.5 | 3.50% | 41% | Undervalued |
| CI | Cigna | $286 | 8.5x | 1.8 | 2.18% | 16% | Undervalued |
| NEM | Newmont | $108 | 9.4x | 2.2 | — | 26% | Undervalued |
| ING | ING Group | $31 | 9.7x | 1.0 | — | 17% | Undervalued |
| BCS | Barclays | $24 | 7.0x | 0.5 | — | — | Deep value (below book) |
| HCA | HCA Healthcare | $394 | 11.9x | — | — | — | Fair to undervalued |
Key Insights
- Cheapest: BCS (7.0x PE, below book), PDD (6.67x PE), CMCSA (6.61x PE)
- Most stable: GSK (ROE 41%, 3.5% dividend), ING (ROE 17%, below book)
- Best upside: ADBE (9.3x PE + 59% ROE, Firefly AI catalyst), ACN (12x PE, AI consulting demand)